Skip to content

REMEDENT, INC.: 10-Q filed 2013-02-14

What REMEDENT, INC. reported in its quarterly report filed 2013-02-14 (fiscal Q3 2012): 41 published measures, 116 facts as tagged in accession 0001144204-13-008459.

This filing

Form
10-Q (quarterly report)
Filed
2013-02-14
Fiscal period
fiscal Q3 2012
Accession
0001144204-13-008459 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All REMEDENT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-12-316,182,983USD
At 2012-03-316,965,097USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-12-315,603,323USD
At 2012-03-315,059,884USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-12-31562,298USD
At 2012-03-311,887,851USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-12-3112,990USD
At 2012-03-31203,584USD
At 2011-12-311,340,274USD
At 2011-03-311,662,520USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-04-01 to 2012-12-31-1,036,909USD275
2011-04-01 to 2011-12-311,399,403USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2012-04-01 to 2012-12-311,572,511USD275
2011-04-01 to 2011-12-318,413,610USD275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-04-01 to 2012-12-31434,612USD275
2011-04-01 to 2011-12-31965,875USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-04-01 to 2012-12-31523,611USD275
2011-04-01 to 2011-12-31-2,581,126USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-12-31-22,027,195USD
At 2012-03-31-20,622,635USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2012-10-01 to 2012-12-3119,995,969shares92
2012-04-01 to 2012-12-3119,995,969shares275
2011-10-01 to 2011-12-3119,995,969shares92
2011-04-01 to 2011-12-3119,995,969shares275

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2012-10-01 to 2012-12-3119,995,969shares92
2012-04-01 to 2012-12-3119,995,969shares275
2011-10-01 to 2011-12-3119,995,969shares92
2011-04-01 to 2011-12-3119,995,969shares275

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-0.02USD/shares92
2012-04-01 to 2012-12-31-0.07USD/shares275
2011-10-01 to 2011-12-31-0.01USD/shares92
2011-04-01 to 2011-12-31-0.05USD/shares275

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-0.02USD/shares92
2012-04-01 to 2012-12-31-0.07USD/shares275
2011-10-01 to 2011-12-31-0.01USD/shares92
2011-04-01 to 2011-12-31-0.05USD/shares275

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-10-01 to 2012-12-31153USD92
2012-04-01 to 2012-12-31153USD275
2011-10-01 to 2011-12-31105,804USD92
2011-04-01 to 2011-12-31314,809USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-12-31699,949USD
At 2012-03-31641,220USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-04-01 to 2012-12-310USD275
2011-04-01 to 2011-12-3139,075USD275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-515,281USD92
2012-04-01 to 2012-12-31-1,901,921USD275
2011-10-01 to 2011-12-31-220,575USD92
2011-04-01 to 2011-12-31-131,602USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-12-313,092,929USD
At 2012-03-313,268,854USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-10-01 to 2012-12-3156,555USD92
2012-04-01 to 2012-12-31153,811USD275
2011-10-01 to 2011-12-31117,512USD92
2011-04-01 to 2011-12-31345,600USD275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-12-314,375,620USD
At 2012-03-313,607,361USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-12-311,071,210USD
At 2012-03-311,009,176USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-12-31618,138USD
At 2012-03-31838,240USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-10-01 to 2012-12-31882,877USD92
2012-04-01 to 2012-12-312,603,631USD275
2011-10-01 to 2011-12-311,993,898USD92
2011-04-01 to 2011-12-316,602,684USD275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-12-311,060,839USD
At 2012-03-311,077,766USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-31367,596USD92
2012-04-01 to 2012-12-31701,710USD275
2011-10-01 to 2011-12-311,773,323USD92
2011-04-01 to 2011-12-316,471,082USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-10-01 to 2012-12-3114,509USD92
2012-04-01 to 2012-12-3143,948USD275
2011-10-01 to 2011-12-3147,513USD92
2011-04-01 to 2011-12-31280,895USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-12-3119,995,969shares
At 2012-03-3119,995,969shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2012-12-31579,660USD
At 2012-03-311,905,213USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2012-12-311,227,703USD
At 2012-03-311,452,523USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-12-312,161,805USD
At 2012-03-312,039,375USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-12-311,461,856USD
At 2012-03-311,398,155USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-12-31467,064USD
At 2012-03-31536,331USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-435,361USD92
2012-04-01 to 2012-12-31-1,404,408USD275
2011-10-01 to 2011-12-3199,248USD92
2011-04-01 to 2011-12-3158,911USD275

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-463,596USD92
2012-04-01 to 2012-12-31-1,325,556USD275
2011-10-01 to 2011-12-31-987,043USD92
2011-04-01 to 2011-12-31-1,905,141USD275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-435,514USD92
2012-04-01 to 2012-12-31-1,404,561USD275
2011-10-01 to 2011-12-31-264,212USD92
2011-04-01 to 2011-12-31-1,023,201USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-10-01 to 2012-12-31571,464USD92
2012-04-01 to 2012-12-311,743,363USD275
2011-10-01 to 2011-12-311,120,535USD92
2011-04-01 to 2011-12-313,713,496USD275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2012-10-01 to 2012-12-31-4,715USD92
2012-04-01 to 2012-12-31-10,382USD275
2011-10-01 to 2011-12-310USD92
2011-04-01 to 2011-12-310USD275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-10-01 to 2012-12-3179,920USD92
2012-04-01 to 2012-12-31497,513USD275
2011-10-01 to 2011-12-31319,823USD92
2011-04-01 to 2011-12-31190,513USD275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-12-31-220,102USD275
2011-04-01 to 2011-12-31-821,672USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-12-31-16,927USD275
2011-04-01 to 2011-12-31-231,279USD275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-04-01 to 2012-12-3152,763USD275
2011-04-01 to 2011-12-31-134,035USD275

Inspect the source

Entity
REMEDENT, INC. / CIK 0001078037
Captured
SEC response SHA-256
45fceec6324be1015fe5b91364230644b1829b27482c22b4c8e0a8b6c3dc5393

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001078037.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))